|Bid||0.00 x 900|
|Ask||0.00 x 900|
|Day's Range||30.52 - 31.93|
|52 Week Range||13.43 - 41.99|
|Beta (5Y Monthly)||3.34|
|PE Ratio (TTM)||75.27|
|Forward Dividend & Yield||0.04 (0.13%)|
|Ex-Dividend Date||Apr 30, 2021|
|1y Target Est||N/A|
Institutional investors, portfolio managers, financial analysts, CIOs and other investment community professionals who invest in the energy space should register now for The Oil & Gas Conference® which will take place Aug. 15-18, 2021, at the Denver Downtown Westin hotel.
Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core", "Core Lab", or the "Company") reported continuing operations resulted in first quarter 2021 revenue of $108,400,000. Core's operating income was $11,600,000, with earnings per diluted share ("EPS") of $0.18, all in accordance with U.S. generally accepted accounting principles ("GAAP"). Operating income, ex-items, a non-GAAP financial measure, was $12,000,000, yielding operating margins of 11.0% and EPS, ex-items, of $0.15. A full reconciliation of non-GAAP financial measures and year-over-year comparisons are included in the attached financial tables.
Core Laboratories (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") will broadcast its first quarter 2021 conference call over the Internet at 7:30 a.m. CDT / 2:30 p.m. CEST on April 22, 2021.